RECURSION PHARMACEUTICALS-A (RXRX) Institutional Ownership and Insiders Activity

RECURSION PHARMACEUTICALS-A (RXRX) is widely held by institutional investors, with 3 tracked firms reporting positions valued at approximately $130.87M based on SEC Form 13F filings for the quarter ended March 31, 2026.

ARK Invest is the largest disclosed holder, reporting approximately $123.45M in RXRX holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with ARK Invest representing the majority of disclosed value.